Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

News > All

Total search results: 16802 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AgomAb Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent. 2019-04-03
Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. 2019-04-03
Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen. 2019-04-03
Exscientia Ltd.. (4/3/19). "Press Release: Exscientia Achieves Molecule Discovery Milestone as Part of GSK Collaboration". Oxford. 2019-04-03
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Editas Medicine, Inc.. (4/3/19). "Press Release: Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms". Cambridge, MA. 2019-04-03
Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data". Brisbane, CA. 2019-04-02
Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. 2019-04-02
Curetis N.V.. (4/2/19). "Press Release: Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance". Amsterdam & Holzgerlingen. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy". Brisbane, CA & New York, NY. 2019-04-02
Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. 2019-04-02
Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel. 2019-04-02
Immunic AG. (4/2/19). "Press Release: Immunic Therapeutics to Present at the Needham Healthcare Conference on April 10". Planegg-Martinsried. 2019-04-02
Bayer AG. (4/2/19). "Press Release: Leaps by Bayer and Khloris Join Forces to Develop Induced Pluripotent Stem Cells (iPSCs) as Breakthrough Anti-cancer Vaccines". Leverkusen & South San Francisco, CA. 2019-04-02
Bio-Rad Laboratories, Inc.. (4/2/19). "Press Release: Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer". Hercules, CA. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Announces Agreement Securing Access To Large-scale, Commercial-grade Manufacturing Capacity at Brammer Bio". Brisbane, CA. 2019-04-02
Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. 2019-04-01
Cell Mogrify Ltd.. (4/1/19). "Press Release: Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic". Cambridge. 2019-04-01
Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. 2019-04-01
MorphoSys AG. (4/1/19). "Press Release: Dr. Sarah Fakih Joins MorphoSys as Head of Corporate Communications and Investor Relations". Planegg. 2019-04-01
Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA. 2019-04-01
Affimed N.V.. (4/1/19). "Press Release: Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting". He 2019-04-01
Cambridge Innovation Capital plc. (4/1/19). "Press Release: Cambridge Innovation Capital Completes £150 Million New Capital Raise". 2019-04-01
Mologic Ltd.. (4/1/19). "Press Release: Mologic Expands US and UK Operations. Strengthens Team as Part of Continued International Expansion – Bolsters US Presence with the Opening of Subsidiary in Boston, MA". Bedfordshire. 2019-04-01
Novartis AG. (4/1/19). "Press Release: AveXis Expands World-leading Gene Therapy Manufacturing Capacity with Purchase of Advanced Biologics Therapy Manufacturing Campus in Longmont, Colorado". Basel. 2019-04-01
Congenica Ltd.. (4/1/19). "Press Release: Congenica Announces On-Premise Deployment Option for its Sapientia Platform". Cambridge. 2019-04-01
Evotec SE. (4/1/19). "Press Release: Evotec AG Completes Conversion into Evotec SE". Hamburg. 2019-04-01
Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. 2019-04-01
Roche. (4/1/19). "Press Release: Roche’s Ipatasertib in Combination with Tecentriq and Chemotherapy Shows Promising Anti-tumour Activity in Triple-negative Breast Cancer in Early Phase Trial". Basel. 2019-04-01
Illumina, Inc.. (3/29/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Germany". San Diego, CA. 2019-03-29
Bluebird Bio, Inc.. (3/29/19). "Press Release: Bluebird Bio Receives Positive Opinion from CHMP for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA. 2019-03-29
ProteoNic Biotechnology B.V.. (3/28/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Bayer". Leiden. 2019-03-28
Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. 2019-03-28
Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow. 2019-03-28
Evotec AG. (3/28/19). "Press Release: Evotec AG Fiscal Year 2018 Results – Accelerated Growth and Strong Long-term Outlook". Hamburg. 2019-03-28
Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert. 2019-03-28
Indivumed GmbH. (3/28/19). "Press Release: Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services". Hamburg & Westminster, CO. 2019-03-28
Selvita S.A.. (3/28/19). "Press Release: Selvita Posts 67 Percent Increase in Operating Profit for Services Division, Innovative Research Division Reaches Inflection Point as SEL120 Enters Clinical Development". Krakow. 2019-03-28
ArcherDX, Inc.. (3/28/19). "Press Release: ArcherDX Announces Collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients". Boulder, CO. 2019-03-28
Celyad S.A.. (3/28/19). "Press Release: Celyad Appoints Filippo Petti as Chief Executive Officer. Dr Christian Homsy Continues as Non-executive Director and Chair of the Strategy Committee of the Board of Directors". Mont-Saint-Guibert. 2019-03-28
Probiodrug AG. (3/28/19). "Press Release: Probiodrug Reports Full Year 2018 Financial Results". Halle (Saale). 2019-03-28
Qiagen N.V.. (3/28/19). "Press Release: Qiagen Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research". Germantown, MD & Hilden. 2019-03-28
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. 2019-03-28
Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. 2019-03-27
Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin. 2019-03-27
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. 2019-03-27
Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. 2019-03-27
Evaluate Ltd.. (3/26/19). "Press Release: Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer". London, Boston, MA & Tokyo. 2019-03-26
MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. 2019-03-26
Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev. 2019-03-26
Curetis N.V.. (3/26/19). "Press Release: Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero". Amsterdam & Holzgerlingen. 2019-03-26
Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". 2019-03-26
Evotec AG. (3/26/19). "Press Release: Evotec and The Mark Foundation for Cancer Research Announce Strategic Collaboration in Immuno-oncology". Hamburg. 2019-03-26
Sphere Fluidics Ltd.. (3/26/19). "Press Release: Sphere Fluidics Hires 10 New UK and US Staff in Its Plan to Scale Internationally". Cambridge. 2019-03-26
Synerkine Pharma B.V.. (3/25/19). "Press Release: Synerkine Pharma Raises EUR3.3 Million in Series A Financing". Utrecht. 2019-03-25
PharmaMar S.A.. (3/25/19). "Press Release: PharmaMar Announces Positive Results in Its Lurbinectedin Monotherapy Trial for Small Cell Lung Cancer". Madrid. 2019-03-25
F-Star Biotechnology Ltd.. (3/25/19). "Press Release: F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting". Cambridge. 2019-03-25
Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA. 2019-03-25
Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA. 2019-03-24
Exscientia Ltd.. (3/22/19). "Press Release: Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia". Oxford & Osaka. 2019-03-22
Exscientia Ltd.. (3/21/19). "Press Release: Celgene and Exscientia Enter 3-year AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity". Oxford. 2019-03-21
Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. 2019-03-21
Cambridge Cancer Genomics Ltd.. (3/21/19). "Press Release: Genomics England and Cambridge Cancer Genomics (CCG.ai) Announce Immunotherapy Partnership". Cambridge. 2019-03-21
Pierre Fabre S.A.. (3/21/19). "Press Release: Institut Curie and Pierre Fabre Strengthen Their Immuno-oncology Partnership". Paris & Castres. 2019-03-21
Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. 2019-03-21
Atlatl Innovation Cluster. (3/20/19). "Press Release: Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai". Shanghai. 2019-03-20
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". 2019-03-20
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
bioMérieux S.A.. (3/19/19). "Press Release: Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury". Deerfield, IL & Marcy l’Etoile. 2019-03-19
Roche. (3/19/19). "Press Release: FDA Approves Roche’s Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-stage Small Cell Lung Cancer". Basel. 2019-03-19
Affimed N.V.. (3/19/19). "Press Release: Affimed Announces Milestone Payment from Genentech and ROCK Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity". Heidelberg. 2019-03-19
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
Karuna Therapeutics, Inc.. (3/18/19). "Press Release: Karuna Announces $68 Million Series B Financing". Boston, MA. 2019-03-18
Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. 2019-03-18
Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. 2019-03-18
Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin. 2019-03-18
Cell Mogrify Ltd.. (3/18/19). "Press Release: Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies". Cambridge. 2019-03-18
SilverSky LifeSciences GmbH. (3/18/19). "Press Release: DxPx – The First International Diagnostics Partnering Conference". Düsseldorf. 2019-03-18
Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. 2019-03-14
Argenx SE. (3/14/19). "Press Release: Argenx to Receive First Clinical Milestone Payment for Product Candidate Developed". Breda & Ghent. 2019-03-14
Cambrex Corporation. (3/14/19). "Press Release: Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan". East Rutherford, NJ. 2019-03-14
Merck KGaA. (3/14/19). "Press Release: Merck Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-03-14
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. 2019-03-14
AstraZeneca plc. (3/14/19). "Press Release: AstraZeneca Showcases Next-generation Oncology Pipeline Addressing Unmet Patient Needs at AACR Annual Meeting". 2019-03-14
Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. 2019-03-14
CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. 2019-03-14
MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. 2019-03-13
MorphoSys AG. (3/13/19). "Press Release: MorphoSys Presents Results for Fiscal Year 2018". Planegg. 2019-03-13
ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. 2019-03-12
iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva. 2019-03-12
Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. 2019-03-12
Minoryx Therapeutics S.L.. (3/12/19). "Press Release: Minoryx Therapeutics Appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of Its Belgian Subsidiary". Mataró, Barcelona & Charleroi. 2019-03-12
Olink Proteomics. (3/12/19). "Press Release: Summa Equity Acquires Olink Proteomics". 2019-03-12
Oxford BioMedica plc. (3/12/19). "Press Release: Oxford Biomedica Announces R&D Collaboration with Microsoft to Improve Gene and Cell Therapy Manufacturing Using the Intelligent Cloud and Machine Learning". Oxford. 2019-03-12
BRAIN AG. (3/12/19). "Press Release: Global Beverage Company Has Joined the DOLCE Program. New Member Gains Access to DOLCE Sweet Solutions in the Field of Beverages". Zwingenberg, Potsdam & La Madeleine Cedex. 2019-03-12
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top